sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Stem Cell Therapy Market Scope And Analysis

  • Report Code : TIPHE100000991
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Stem Cell Therapy Market Scope and Analysis by 2031

Buy Now

Stem Cell Therapy Market Report Stem Cell Therapy Market Size and Share Stem Cell Therapy Market Scope and Analysis

Stem Cell Therapy Market Report Scope

Report Attribute Details
Market size in 2023 US$ 3.5 Billion
Market Size by 2031 US$ 8.9 Billion
Global CAGR (2023 - 2031) 8.7%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Adult Stem Cell Therapy
  • Embryonic Stem Cell Therapy
  • Induced Pluripotent Stem Cell Therapy
  • Other Stem Cell Therapy
By Treatment
  • Allogeneic
  • Autologous
By Application
  • Musculoskeletal
  • Dermatology
  • Cardiology
  • Drug Discovery and Development
  • Other Applications
By End User
  • Hospitals & Specialty Clinics
  • Academic & Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • MEDIPOST
  • RichSource
  • BioTime Inc
  • Mesoblast Limited
  • Holostem Terapie Avanzate Srl
  • US Stem Cell Inc
  • TiGenix NV
  • AlloSource
  • NuVasive Inc
  • JCR Pharmaceuticals Co Ltd